Immune infiltration has been correlated with survival of patients with colorectal cancer. In this issue, Ziegler et al. reveal complex and unexpected connections between loss of STAT3, mitophagy, and the induction of an adaptive immune response that limits the growth of colorectal carcinoma.
In Lewis Caroll's classic poem, The Walrus and the Carpenter, the walrus invites the oysters to walk and ''talk of many things,'' ''of shoes and ships and sealing wax and cabbages and kings'' (http://www.jabberwocky.com/ carroll/walrus.html). Loss of STAT3 in intestinal epithelial cells (IEC) has been shown to limit tumor formation, but how it does so is unclear. In this issue of Cell, Ziegler et al. (2018) likewise ''talk of many things,'' proposing a complex pathway that connects STAT3 and colorectal cancer (CRC). They report that STAT3 loss in IEC promoted mitophagy, which in turn led to lysosomal membrane permeabilization (LMP) and cathepsin release. The proteolytic activity of cathepsins facilitated the generation of peptides that are exposed on MHC class I molecules, stripped off the IEC by dendritic cells (DC), and presented to T cells, a chain of events resulting in the clearance of tumorigenic IEC, to limit the development of CRC ( Figure 1 ).
The authors began by extending previous observations (Bollrath et al., 2009) showing that Stat3 DIEC mice are resistant to CRC formation induced by a chemical mutagen or to IEC expression of an oncogenic variant of b-catenin. Resistance in the b-catenin CRC model was associated with increased T-cell infiltration, while depletion of DCs using a CD11c Diphtheria toxin receptor approach, or T cells using a blocking CD8 antibody, allowed tumor formation. These results are intriguing because T-cell infiltrate is associated with a much better patient outcome in CRC and prompted the authors to investigate how the T cells became activated in this system. LAMP1 and 2 make up over 50% of all lysosomal membrane proteins (Schwake et al., 2013) . The authors observed a disruption in LAMP2 staining in IEC only 3 days after inducing expression of mutant b-catenin. Upon examining lysosomal function in more detail, the authors found that while cathepsin S and B expression was similar between Stat3 DIEC and wild-type mucosa, they were mislocalized to the cytosol in Stat3 DIEC mice.
The authors therefore speculated that STAT3 normally prevents LMP and cathepsin release into the cytosol in IECs. While cathepsins may be regulated differently in other cell types, it is worth remarking that STAT3 plays the opposite role in mammary epithelial cells during mammary gland involution (Kreuzaler et al., 2011) . Thus, during this biological process, STAT3 was required for cathepsin B and L expression and, perhaps by downregulating the cathepsin inhibitor Spi2A, LMP (Kreuzaler et al., 2011) . Chloroquine treatment also induces LMP, and Ziegler et al. (2018) saw a similar release of cathepsins in IEC from animals treated with chloroquine in vivo. Chloroquine gave rise to an impressive protection from tumorigenesis in b-catenin mutant mice, much better than loss of STAT3 alone. Considering that activation of the wnt/b-catenin pathway is observed in >80% of human CRC and chloroquine is a relatively safe and inexpensive medicine, the therapeutic potential of this treatment seems worth exploring further. The authors were able to reproduce, to a certain extent, this phenomenon in vitro using the colon carcinoma cell line (CMT93) expressing a STAT3 siRNA.
However, the STAT3-deficient cells did not intrinsically undergo LMP, and treatment with hydrogen peroxide was necessary to observe an increased sensitivity compared with wild-type cells. With a further suite of in vitro experiments, the authors proposed that cytosolic cathepsins generate peptides that are loaded onto tumor MHC class I molecules in a TAP1-dependent manner. The involvement of TAP1 suggests that peptides are loaded onto MHC class I molecules via the classic TAP1-dependent intracellular membrane trafficking route before being transferred to DCs via cross-dressing. Conceptually, this raises interesting questions. Given that cathepsin release into the cytosol generates peptides from cytosolic proteins, it is likely to be highly disruptive of cellular function, if not outright destructive. Certainly, LMP has been shown to cause caspase activation, disruption of Golgi function, and cell death (Salvesen et al., 2016) . Hence, there might only be a small window of opportunity in which such a presentation pathway could occur before the cell dies. Perhaps crossdressing can occur from apoptotic cells or does not require MHC class I to be presented on the plasma membrane. It will be interesting to see whether-and if so, for how long-cells must be alive to allow cross-dressing and the relative timing of caspase activation and cell death following LMP. It would have been informative, particularly in interpreting later results, to see whether caspases were activated at these early time points in IECs prior to T cell infiltration or when T cells were blocked with anti-CD8 antibody.
The authors next sought to address how LMP was triggered. Because LMP can be caused by iron(II) accumulation that promotes reactive oxygen species (ROS) generation in the lysosome, they examined this phenomenon in CMT93 cells. In addition to iron(II) accumulation, they also observed increased amounts of a mitochondrial protein, COXII, in lysosomes. This observation implicated increased mitophagy as a potential cause of LMP in their model, and a role for PINK1/Parkin-mediated mitophagy was confirmed by siRNA-mediated silencing of the serine/threonine kinase PINK1.
PINK1, or its downstream effector, the E3 ubiquitin ligase Parkin, are key mediators of the clearance of damaged mitochondria and have been implicated as tumor suppressors in a variety of cancers (Bernardini et al., 2017) . Potentially consistent with this current study, loss of a single allele of parkin is sufficient to promote the incidence and progression of CRC in an Apc min mouse (Poulogiannis et al., 2010) . The mechanisms underpinning this tumor suppressor function are unclear, but limiting the production of ROS from damaged mitochondria, limiting a metabolic switch to aerobic glycolysis, or inhibiting the levels of G1/S cyclins have been postulated (Gong et al., 2014; Zhang et al., 2011) . A link between mitophagy, LMP, and antigen presentation to promote an anti-tumor immune response, as proposed in this study, provides another mechanism. These findings are intriguing given that it has been reported that under inflammatory conditions, PINK1-dependent mitophagy suppresses, rather than induces, the presentation of mitochondrial antigens (Matheoud et al., 2016) . Additionally, it remains unclear what drives induction of mitophagy in the absence of STAT3. The authors concede that elevated oxidative phosphorylation, as observed in STAT3-deficient IEC, is not commonly a trigger of mitophagy. Although the physiological triggers are less clear, inhibitors of mitochondrial respiration are commonly used to induce PINK1/Parkin-dependent mitophagy in the lab. Recent studies have questioned whether PINK1/Parkin plays a role in the routine maintenance of the mitochondrial pool (McWilliams et al., 2018) , suggesting that some type of insult is required to activate PINK1. How reduction of STAT3 levels might promote this process remains an open question.
At the end of Caroll's poem, the carpenter asks the oysters to walk back, ''But answer came there none -and this was scarcely odd, because they'd eaten every one.'' Unlike the oysters, oncogenic STAT3-deficient IEC digest themselves but surprisingly appear able to co-opt the process to actively send an alarm to Upon oncogenic stress, loss of STAT3 in IEC upregulates mitophagy, which in turn promotes LMP and cathepsin release. The proteolytic activity of cathepsin facilitates the generation of peptides that are exposed on MHC class I molecules, stripped off IEC by DC and presented to T cells, a chain of events resulting in the clearance of tumorigenic IEC to limit the development of CRC. DC, dendritic cells; IEC, intestinal epithelial cells; LMP, lysosomal membrane permeabilization; STAT3, the transcription factor STAT3; CD8 T, CD8-positive T cells. the immune system. Determining the signals that prompt the initial mitochondrial clearance or how this process can be manipulated therapeutically will be the next frontiers.
When T cells respond to infectious agents, they differentiate into effector and memory cells. In this issue of Cell, Smith et al. use a genetic ''time-stamping'' method to show that the developmental time the T cell arises-near birth or as an adult-dictates what type of T effector or memory cell results.
In the poem ''My Heart Leaps Up,'' Wordsworth implies that man is the product of his habits and behavior developed in childhood. This appears true for T cells as well, as revealed in this issue of Cell (Smith et al., 2018) reveal this. For decades, immunologists have sought explanations for the heterogeneous nature of effector T cell responses. Many experiments have focused on differences in T cell receptor affinity, precursor frequency, and the timing of antigen encounter to explain variation in the ensuing effector and memory populations. Smith et. al (2018) now show that developmental origin also plays a surprisingly large role in determining the phenotypic and functional characteristics of effector T cells and the memory cells they become.
The current study by Smith and colleagues introduces an elegant ''timestamp'' (ts) mouse model in which CD4 CreERT2 x ROSA Tomato fl-stop mice were treated with tamoxifen at either day 1 or day 28 of life (Smith et al., 2018) . This labeled two distinct ''waves'' of CD8+ T cells (one of fetal/neonatal origin and one of adult origin) as they went through development in the thymus (Figure 1 ). This approach was successful, because CD4
Cre is expressed only transiently during the double-positive stage of development of CD8+ T cells. Using this model, the authors studied 8-week-old animals and found that CD8+ T cells marked at day 1 versus day 28 of life differed in remarkable ways. Day 1 ts cells contained a much higher proportion of ''virtual memory'' (VM) cells (Smith et al., 2018) 
